Eton Pharmaceuticals (ETON) Treasury Shares (2017 - 2018)
Eton Pharmaceuticals' (ETON) quarterly Treasury Shares came in at $6.7 million in Q3 2018, little changed quarter-over-quarter from $6.7 million in Q2 2018.
Analysis
Eton Pharmaceuticals (ETON) Treasury Shares (2017 - 2018) Analysis & Trends
Eton Pharmaceuticals has disclosed Treasury Shares across 2 years of filings, most recently posting $6.7 million for Q3 2018.
- In Q3 2018, Treasury Shares changed N/A year-over-year to $6.7 million; the TTM figure through Sep 2018 stood at $6.7 million (changed N/A YoY), while the FY2017 annual figure was $6.7 million, changed N/A from the prior year.
- Treasury Shares came in at $6.7 million for Q3 2018 at Eton Pharmaceuticals, roughly flat from $6.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $6.7 million in Q4 2017 to a low of $6.7 million in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 64.13 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 3.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 35.35 Mn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.63 Bn | 25.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 6.69 Mn |
| Sep 30, 2018 | 6.69 Mn |
| Jun 30, 2018 | 6.69 Mn |
| Jun 30, 2018 | 6.69 Mn |
| Mar 31, 2018 | 6.69 Mn |
| Mar 31, 2018 | 6.69 Mn |
| Dec 31, 2017 | 6.69 Mn |
| Dec 31, 2017 | 6.69 Mn |